University Of Skane

The research at University Of Skane includes studies in hemic and lymphatic diseases focused on hemophilia A and multiple myeloma. These trials are designed to evaluate new treatment approaches, improve disease control, and compare strategies that may lead to better long-term outcomes for patients.

• Testing a new gene-based therapy approach for hemophilia A
• Comparing treatment strategies for newly diagnosed multiple myeloma

This work reflects a strong interest in advancing care for blood-related cancers and inherited bleeding disorders through more effective therapies.

Clinical trials in immune system diseases at the Department of Respiratory Medicine are centered on giant cell arteritis and generalized myasthenia gravis. The studies aim to assess safety, tolerability, and treatment effectiveness, helping identify options that may better control inflammation and immune-driven symptoms.

• Evaluating a treatment for giant cell arteritis
• Assessing safety and tolerability in generalized myasthenia gravis

These trials support efforts to improve outcomes in autoimmune conditions where managing immune activity is central to patient care.

Research in neoplasms includes studies of stage III colorectal cancer and multiple myeloma. The focus is on personalizing treatment, improving survival, and testing whether different therapy choices can better match the needs of individual patients.

• Personalizing post-surgery treatment for stage III colorectal cancer
• Comparing treatment pathways in multiple myeloma

At University Of Skane, this area highlights efforts to refine cancer care using approaches that may improve effectiveness while reducing unnecessary treatment burden.

The site is also active in nervous system diseases, particularly amyotrophic lateral sclerosis. These trials are exploring new therapies and evaluating whether they can slow progression, preserve function, and improve quality of life for people living with this serious neurological condition.

• Studying potential treatments for amyotrophic lateral sclerosis
• Assessing functional outcomes and disease control in ALS

This research area shows a clear emphasis on finding better options for neurodegenerative disease management.

Clinical research in respiratory tract diseases includes studies of congenital alpha-1 antitrypsin deficiency and related airflow limitation. The trials are aimed at testing inhaled treatment approaches, improving lung function, and understanding whether new therapies can help patients breathe more easily over time.

• Evaluating a new inhaled therapy for alpha-1 antitrypsin deficiency
• Measuring changes in lung function in chronic respiratory disease

With its focus on chronic lung conditions, this work supports better treatment development for patients with long-term respiratory impairment.